News Releases

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

December 4, 2024

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

November 22, 2024

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

November 18, 2024

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 8, 2024

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 6, 2024

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

October 31, 2024

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

October 28, 2024

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

October 15, 2024

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

October 7, 2024

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

September 30, 2024

1
2
3
4
5
6
7
8
9
10
...26
Next »

Latest News & Events

Dec 4, 2024

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

Read More...

Nov 22, 2024

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Read More...

Nov 18, 2024

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

Read More...